CM Management’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.55M Hold
2,100,000
2.97% 7
2025
Q4
$2.98M Hold
2,100,000
2.51% 10
2025
Q3
$3.44M Sell
2,100,000
-150,000
-7% -$167K 2.87% 8
2025
Q2
$1.65M Buy
2,250,000
+102,500
+5% +$88.5K 1.5% 25
2025
Q1
$1.73M Buy
2,147,500
+97,500
+5% +$112K 1.74% 26
2024
Q4
$2.83M Buy
2,050,000
+50,000
+3% +$56.1K 2.53% 13
2024
Q3
$2.08M Buy
2,000,000
+900,000
+82% +$1.23M 1.66% 28
2024
Q2
$1.9M Buy
1,100,000
+100,000
+10% +$201K 1.75% 23
2024
Q1
$2.39M Buy
1,000,000
+176,000
+21% +$433K 2.01% 18
2023
Q4
$2.74M Buy
824,000
+276,000
+50% +$739K 2.21% 13
2023
Q3
$2.05M Buy
548,000
+98,000
+22% +$453K 2.17% 15
2023
Q2
$1.92M Buy
450,000
+250,000
+125% +$1.48M 1.87% 18
2023
Q1
$1.37M Buy
200,000
+25,000
+14% +$194K 1.62% 20
2022
Q4
$1.39M Sell
175,000
-25,000
-13% -$192K 1.66% 17
2022
Q3
$1.92M Hold
200,000
2.15% 16
2022
Q2
$1.45M Buy
200,000
+50,000
+33% +$435K 1.54% 25
2022
Q1
$1.94M Buy
150,000
+25,000
+20% +$318K 1.63% 23
2021
Q4
$2M Hold
125,000
1.51% 19
2021
Q3
$2.01M Buy
125,000
+25,000
+25% +$366K 1.5% 17
2021
Q2
$1.38M Buy
100,000
+25,000
+33% +$354K 1% 34
2021
Q1
$1.1M Buy
75,000
+15,000
+25% +$255K 0.81% 49
2020
Q4
$1.04M Buy
+60,000
New +$1.07M 0.97% 33

Other funds holding CHRS